1st fully AI designed drug for lung disease enters human clinical trials
Hong Kong, July 3 (SocialNews.XYZ) In a first, a drug discovered and designed using artificial intelligence (AI) for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic disease that causes scarring in the lungs, has…